1. Evidence-Based Editorial Governance & GRADE Methodology
Every clinical assertion, drug titration schedule, and safety threshold on Safe Infusion Therapy is grounded in peer-reviewed medical literature. We utilize the international GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) to classify evidence quality:
GRADE Evidence Hierarchy:
- High Quality (Grade A): Consistent evidence from well-designed randomized controlled trials (RCTs) or large prospective multicenter registries.
- Moderate Quality (Grade B): Evidence from randomized trials with methodological limitations, large observational cohorts, or well-conducted clinical series.
- Low / Expert Consensus (Grade C): Case-control studies, retrospective series, or consensus statements from accredited professional societies (INS, CDC, ASCO).
2. The 5-Stage Editorial Review Workflow
The 5-Stage Editorial Lifecycle:
- 1. Literature Surveillance & Extraction: Continuous monitoring of primary medical journals, FDA alerts, and professional society updates.
- 2. Clinical Drafting: Drafted by specialized clinical authors with advanced vascular access credentials.
- 3. Multi-Disciplinary Blind Peer Review: Independent evaluation by at least two Medical Review Board members (Physician + Nurse or Pharmacist).
- 4. Crossref DOI & Data Validation: Programmatic verification of all literature citations and digital object identifiers.
- 5. Annual Re-Certification: Comprehensive annual audit of all published routes against emerging practice guidelines.